Regional Ventilation During High Flow Nasal Cannula and Conventional Nasal Cannula in Patients With Hypoxia
Comparison of Regional Ventilation Pattern During High Flow Nasal Cannula Between Conventional Low Flow System Nasal Cannula in Patients With Mild to Moderate Hypoxia
1 other identifier
interventional
24
0 countries
N/A
Brief Summary
High-flow nasal cannula (HFNC) that uses heated and humidified oxygen was recently introduced for bedside care. It has been shown to be associated with reduced risks of tracheal intubation rates and mortality in adult hypoxic patients. The mechanisms of the effects of HFNC are thought to be related to the favorable effects of the heated and humidified gas, the high-flow rate used to minimize the entrainment of room air, and an increase in the ventilation efficiency, including the elimination of nasopharyngeal dead space, positive end-expiratory pressure (PEEP) effects, and improvements in paradoxical abdominal movement. Regarding the effects on lung volume, global ventilation in the lungs increases during HFNC, which is thought to attribute to PEEP effects. However, how regional ventilation is affected during HFNC in comparison with conventional NC remains unknown. Because PEEP in mechanically ventilated patients improves the regional homogeneity of ventilation, investigators postulated that HFNC via PEEP effects would result in more homogeneous regional distributions in the ventilation changes. Investigators therefore assessed global and regional ventilation in patients with hypoxia receiving care via HFNC using electric impedance tomography and compared these results with conventional nasal cannula.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2014
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 21, 2016
CompletedFirst Posted
Study publicly available on registry
October 25, 2016
CompletedOctober 25, 2016
October 1, 2016
5 months
October 21, 2016
October 23, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Tidal variation
Tidal variation using electric impedance tomography
Twenty minutes after each oxygen therapy. (At the end of each oxygen therapy)
Secondary Outcomes (3)
Oxygen saturation
Twenty minutes after each oxygen therapy. (At the end of each oxygen therapy)
Respiration Rate
Twenty minutes after each oxygen therapy. (At the end of each oxygen therapy)
Subjective comfort
Twenty minutes after each oxygen therapy. (At the end of each oxygen therapy)
Study Arms (2)
HFNC first
ACTIVE COMPARATORPatients in "HFNC first" receive oxygen therapy using HFNC in ahead of conventional nasal cannula oxygen therapy. After 20 minutes of HFNC therapy, patients receive conventional nasal cannula oxygen therapy.
LFS first
ACTIVE COMPARATORPatients in "LFS first" receive oxygen therapy using conventional nasal cannula in ahead of HFNC therapy. After 20 minutes of conventional nasal cannula oxygen therapy, patients receive HFNC oxygen therapy.
Interventions
Eligibility Criteria
You may qualify if:
- Age \>20 years
- Subjective dyspnea in room air
- SaO2\< 90% in room air
- Oxygen requirement for nasal cannula \< 6 L/m
You may not qualify if:
- Unstable vital signs
- SBP \<90 mmHg
- DBP \< 60 mmHg
- Heart rate \> 120 bpm
- Respiratory rate \> 30 bpm
- Persistent dyspnea under oxygen therapy using NC
- Severe hypoxia
- PaO2/FiO2\< 200 mmHg
- Unable to cooperate
- Delirium
- Reduced cognitive function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Spoletini G, Alotaibi M, Blasi F, Hill NS. Heated Humidified High-Flow Nasal Oxygen in Adults: Mechanisms of Action and Clinical Implications. Chest. 2015 Jul;148(1):253-261. doi: 10.1378/chest.14-2871.
PMID: 25742321BACKGROUNDRiera J, Perez P, Cortes J, Roca O, Masclans JR, Rello J. Effect of high-flow nasal cannula and body position on end-expiratory lung volume: a cohort study using electrical impedance tomography. Respir Care. 2013 Apr;58(4):589-96. doi: 10.4187/respcare.02086.
PMID: 23050520BACKGROUNDHsu CF, Cheng JS, Lin WC, Ko YF, Cheng KS, Lin SH, Chen CW. Electrical impedance tomography monitoring in acute respiratory distress syndrome patients with mechanical ventilation during prolonged positive end-expiratory pressure adjustments. J Formos Med Assoc. 2016 Mar;115(3):195-202. doi: 10.1016/j.jfma.2015.03.001. Epub 2015 Apr 3.
PMID: 25843526BACKGROUNDLee DH, Kim EY, Seo GJ, Suh HJ, Huh JW, Hong SB, Koh Y, Lim CM. Global and Regional Ventilation during High Flow Nasal Cannula in Patients with Hypoxia. Acute Crit Care. 2018 Feb;33(1):7-15. doi: 10.4266/acc.2017.00507. Epub 2018 Jan 22.
PMID: 31723854DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chae-Man Lim, MD
Pulmonary and Critical Care Medicine, Asan Medical Center, College of Medicine, University of Ulsan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pulmonary and Critical Care Medicine, College of Medicine, University of Ulsan. Chief Director of Intensive Care Units, Asan Medical Center
Study Record Dates
First Submitted
October 21, 2016
First Posted
October 25, 2016
Study Start
September 1, 2014
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
October 25, 2016
Record last verified: 2016-10